Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CG Oncology (CGON) Gross Margin: 2023-2025

Historic Gross Margin for CG Oncology (CGON) over the last 2 years, with Sep 2025 value amounting to 5.34%.

  • CG Oncology's Gross Margin fell 9466.00% to 5.34% in Q3 2025 from the same period last year, while for Sep 2025 it was 28.87%, marking a year-over-year decrease of 7113.00%. This contributed to the annual value of 100.00% for FY2024, which is negligibly% changed negligibly from last year.
  • Per CG Oncology's latest filing, its Gross Margin stood at 5.34% for Q3 2025, which was down 94.66% from 100.00% recorded in Q1 2025.
  • CG Oncology's 5-year Gross Margin high stood at 100.00% for Q1 2023, and its period low was 5.34% during Q3 2025.
  • Moreover, its 3-year median value for Gross Margin was 100.00% (2025), whereas its average is 89.48%.
  • Data for CG Oncology's Gross Margin shows a maximum YoY crashed of 9,466bps (in 2025) over the last 5 years.
  • Over the past 3 years, CG Oncology's Gross Margin (Quarterly) stood at 100.00% in 2023, then remained steady at 100.00% in 2024, then slumped by 9,466bps to 5.34% in 2025.
  • Its Gross Margin was 5.34% in Q3 2025, compared to 100.00% in Q1 2025 and 100.00% in Q4 2024.